Asymmetric Synthesis of Cytotoxic Natural Products
细胞毒性天然产物的不对称合成
基本信息
- 批准号:6742115
- 负责人:
- 金额:$ 2.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2006-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The schiarisanrins are a structurally novel family of lignan natural products that exhibit potent cytotoxicity that were isolated from the fruit of the Chinese medicinal plant Schizandra arisanensis. These agents are derived from the well- represented dibenzocyclooctadiene class of lignans by an oxidative spirocyclization to form the unique 2,4- cyclohexadienone-6-spiro-3'-(2',3'-dihydrobenzo[b]furan) ring system. A synthetic approach to this family of natural products is proposed and is based on a biomimetic strategy for the formation of the spirodihydrobenzo[b]furan ring system. Two strategies for biaryl bond construction are proposed, the first based on an intermolecular coupling of an appropriately substituted 1,4-diarylbutane system, and the second based on novel synthetic methodology for an asymmetric intermolecular biaryl coupling reaction. In the first strategy, the three stereogenic centers of the cyclooctadiene ring will be introduced by an asymmetric allylboration reaction, and 1,4-diarylbutane construction will be completed by a stereoselective hydroboration/Suzuki coupling reaction sequence. In the second strategy, the cyclooctadiene ring will be formed by a ring- closing metathesis reaction of an appropriately substituted chiral biaryl system. The final spirocyclization is proposed to proceed regioselectively from a dioxepin precursor based on an inherent steric bias of the biaryl system. The oximidines are macrocyclic diene and triene lactone natural products that exhibit potent cytotoxicity that is selective for oncogene transformed cells. Studies are proposed for the total synthesis of these agents that feature a novel intramolecular Castro-Stephens coupling for macrolactone formation and a palladium catalyzed coupling between a (Z)-vinyl iodide and a lactam for installation of the enamide side chain.
五味子苷是从中药植物五味子的果实中分离出来的结构新颖的木脂素天然产物家族,具有强大的细胞毒性。 这些试剂源自代表性的二苯并环辛二烯类木脂素,通过氧化螺环化形成独特的2,4-环己二烯酮-6-螺-3'-(2',3'-二氢苯并[b]呋喃)环系统。 提出了该天然产物家族的合成方法,该方法基于形成螺二氢苯并[b]呋喃环系统的仿生策略。 提出了两种联芳键构建策略,第一种基于适当取代的 1,4-二芳基丁烷体系的分子间偶联,第二种基于不对称分子间联芳偶联反应的新颖合成方法。 在第一种策略中,环辛二烯环的三个立体中心将通过不对称烯丙基硼化反应引入,并且1,4-二芳基丁烷的构建将通过立体选择性硼氢化/Suzuki偶联反应序列完成。 在第二种策略中,环辛二烯环将通过适当取代的手性联芳基系统的闭环复分解反应形成。 建议基于联芳基系统固有的空间偏向,从二氧杂环己烷前体区域选择性地进行最终的螺环化。肟胺是大环二烯和三烯内酯天然产物,具有对癌基因转化细胞具有选择性的强效细胞毒性。 提出了对这些试剂的全合成的研究,其特征是用于形成大内酯的新型分子内卡斯特罗-斯蒂芬斯偶联以及用于安装烯酰胺侧链的(Z)-乙烯基碘和内酰胺之间的钯催化偶联。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT S COLEMAN其他文献
ROBERT S COLEMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT S COLEMAN', 18)}}的其他基金
Asymmetric Synthesis of Cytotoxic Natural Products
细胞毒性天然产物的不对称合成
- 批准号:
6624122 - 财政年份:2002
- 资助金额:
$ 2.87万 - 项目类别:
Asymmetric Synthesis of Cytotoxic Natural Products
细胞毒性天然产物的不对称合成
- 批准号:
6882619 - 财政年份:2002
- 资助金额:
$ 2.87万 - 项目类别:
Asymmetric Synthesis of Cytotoxic Natural Products
细胞毒性天然产物的不对称合成
- 批准号:
6472442 - 财政年份:2002
- 资助金额:
$ 2.87万 - 项目类别:
Asymmetric Synthesis of Cytotoxic Natural Products
细胞毒性天然产物的不对称合成
- 批准号:
7019924 - 财政年份:2002
- 资助金额:
$ 2.87万 - 项目类别:
Asymmetric Synthesis of Cytotoxic Natural Products
细胞毒性天然产物的不对称合成
- 批准号:
6882238 - 财政年份:2002
- 资助金额:
$ 2.87万 - 项目类别:
Asymmetric Synthesis of Cytotoxic Natural Products
细胞毒性天然产物的不对称合成
- 批准号:
6728254 - 财政年份:2002
- 资助金额:
$ 2.87万 - 项目类别:
AZINOMYCINS--TOTAL SYNTHESIS AND MECHANISM OF ACTION
阿齐霉素--全合成及作用机制
- 批准号:
6172420 - 财政年份:1995
- 资助金额:
$ 2.87万 - 项目类别:
Azinomycins - Total Synthesis and Mechanism of Action
阿嗪霉素 - 全合成和作用机制
- 批准号:
6693794 - 财政年份:1995
- 资助金额:
$ 2.87万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 2.87万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 2.87万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 2.87万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 2.87万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 2.87万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 2.87万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 2.87万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 2.87万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 2.87万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 2.87万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)














{{item.name}}会员




